My Portfolio

Galderma Group AG GALD-CH:Swiss Exchange

*Data is delayed | Exchange | CHF

Last | 5:31 PM CEST

162.35

-2.05 (-1.25%)

Volume

308,560

52 week range

0.00 - 164.95

Open164.15
Day High164.95
Day Low161.45
Prev Close164.40
52 Week High164.95
52 Week High Date06/03/26
52 Week Low0.00
52 Week Low Date-

Latest On Galderma Group AG

European stocks close lower as Iran war continues to dominate sentimentMarch 5, 2026CNBC.com
Why Trump's 100% drug tariffs could hit Asia and Europe very differentlySeptember 26, 2025CNBC.com
European pharma stocks fall after Trump slaps 100% tariffs on medicinesSeptember 26, 2025CNBC.com
Why U.S. and Asia IPOs are outshining Europe's muted marketSeptember 14, 2025CNBC.com
European markets shrug off new details on EU-U.S. trade agreementAugust 21, 2025CNBC.com
Chocolate, skincare and timepieces: How 39% Swiss tariffs will hit pricesAugust 5, 2025CNBC.com

Key Stats

Market Cap38.623B
Shares Out237.90M
10 Day Average Volume0.50M
Dividend0.35
Dividend Yield0.22%
Beta-

Latest On Galderma Group AG

European stocks close lower as Iran war continues to dominate sentimentMarch 5, 2026CNBC.com
Why Trump's 100% drug tariffs could hit Asia and Europe very differentlySeptember 26, 2025CNBC.com
European pharma stocks fall after Trump slaps 100% tariffs on medicinesSeptember 26, 2025CNBC.com
Why U.S. and Asia IPOs are outshining Europe's muted marketSeptember 14, 2025CNBC.com
European markets shrug off new details on EU-U.S. trade agreementAugust 21, 2025CNBC.com
Chocolate, skincare and timepieces: How 39% Swiss tariffs will hit pricesAugust 5, 2025CNBC.com

KEY STATS

Open164.15
Day High164.95
Day Low161.45
Prev Close164.40
52 Week High164.95
52 Week High Date06/03/26
52 Week Low0.00
52 Week Low Date-
Market Cap38.623B
Shares Out237.90M
10 Day Average Volume0.50M
Dividend0.35
Dividend Yield0.22%
Beta-

RATIOS/PROFITABILITY

EPS (TTM)2.05
P/E (TTM)79.20
Fwd P/E (NTM)-
EBITDA (TTM)968.968M
ROE (TTM)7.69%
Revenue (TTM)4.122B
Gross Margin (TTM)68.96%
Net Margin (TTM)11.68%
Debt To Equity (MRQ)33.48%

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

Barclays Reaffirms Their Buy Rating on Galderma Group AG (GALD)May 18, 2026TipRanks
Barclays Keeps Their Buy Rating on Galderma Group AG (GALD)May 11, 2026TipRanks
Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)May 5, 2026TipRanks
Morgan Stanley Sticks to Its Hold Rating for Galderma Group AG (GALD)April 27, 2026TipRanks
Citi Remains a Buy on Galderma Group AG (GALD)April 25, 2026TipRanks

Profile

Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection...

Thomas Ebeling

Non-Executive Independent Chairman of the Board

Flemming Ornskov M.D.

Chief Executive Officer, Executive Director, Head of the Executive Committee

Thomas Dittrich

Chief Financial Officer, Member of the Executive Committee

Address

Zaehlerweg 10

Zug, ZUG

6300

Switzerland

https://www.galderma.com/